Study of expression levels in MECP2 related disorders using transcriptomics and proteomics: characterizing Rett syndrome and MECP2 duplication syndrome

Autor/a

Pascual Alonso, Ainhoa

Director/a

Armstrong i Morón, Judith

Tutor/a

Cormand Rifà, Bru

Fecha de defensa

2023-07-14

Páginas

259 p.



Departamento/Instituto

Universitat de Barcelona. Departament de Genètica, Microbiologia i Estadística

Resumen

[eng] MECP2 is a multifunctional gene involved in multiple processes such as transcription regulation, chromatin remodelling, splicing and miRNA regulation. Malfunction of MECP2 due to loss of function mutations leads to Rett syndrome (RTT) whereas its overexpression triggers MECP2 duplication syndrome (MDS). Besides, variants in MECP2 can cause a wide spectrum of phenotypes, from severe congenital encephalopathy with early death to mild intellectual disability (ID). RTT and MDS are two well characterized rare diseases with a partly overlapping phenotype consisting of neurodevelopmental delay, ID, impaired muscle tone, lack or unstable ambulation, little or absent speech, gastrointestinal problems, autism like behaviour and hand stereotypies. With next generation sequencing derived methodologies, gigantic breakthroughs have been done in diagnostics and research. These new omic strategies, such as transcriptomic or proteomic, can be applied to patient-derived samples to obtain answers to some of the still unknown aspects of the molecular effect of MECP2 in RTT and MDS. For the present thesis project, patients with alterations in MECP2 were gathered and three cohorts were created and thoroughly studied and characterized: a classic RTT girls group with large deletions within MECP2, a group of patients with MDS together with their duplication carrier mothers, and a group of boys with ID and neurodevelopmental delay with variants in MECP2. Genotype-phenotype correlations were also attempted for these cohorts. In order to further study patients with classic RTT and MDS we decided to use a multi-omic (transcriptomic and proteomic) approach. For that, 22 classic RTT, 17 MDS, 10 MECP2 duplication carriers and 13 healthy controls were gathered and primary cultured cell lines were established from their skin biopsies. DNA, RNA and proteins were extracted from them all and RNA sequencing and tandem mass tag-mass spectrometry (TMT-MS) experiments were performed. The obtained data was analysed in a case-control approach. The multi-omic analysis revealed shared and distinct altered biological processes for each cohort studied. The gene causing RTT and MDS is the same, but its downstream molecular effects might be opposite. Being able to obtain RNA and protein profiles from these patient cohorts seems to be a promising way to better understand MECP2’s role in the underlying pathomechanism triggering RTT and MDS. Differentially expressed genes and proteins involved in cytoskeleton, vesicular activity or immune system were found, and some of them are highlighted as potential biomarker and therapeutic target candidates. Altogether, we aimed to fill the gap by exploring the patients’ genetics, transcriptomics and proteomics in order to get closer to identifying therapeutic targets and biomarkers that could be used in future clinical trials.

Palabras clave

Genètica; Genética; Genetics; Proteòmica; Proteómica; Proteomics; Síndrome de Rett; Rett syndrome; Seqüència de nucleòtids; Cadenas de nucleótidos; Nucleotide sequence; Duplicació de l'ADN; Replicación del ADN; DNA replication

Materias

575 - Genética general. Citogenética general. Inmunogenética. Evolución. Filogenia

Área de conocimiento

Ciències Experimentals i Matemàtiques

Nota

Programa de Doctorat en Genètica / Tesi realitzada a l'Hospital Sant Joan de Déu

Documentos

APA_PhD_THESIS.pdf

6.098Mb

 

Derechos

ADVERTIMENT. Tots els drets reservats. L'accés als continguts d'aquesta tesi doctoral i la seva utilització ha de respectar els drets de la persona autora. Pot ser utilitzada per a consulta o estudi personal, així com en activitats o materials d'investigació i docència en els termes establerts a l'art. 32 del Text Refós de la Llei de Propietat Intel·lectual (RDL 1/1996). Per altres utilitzacions es requereix l'autorització prèvia i expressa de la persona autora. En qualsevol cas, en la utilització dels seus continguts caldrà indicar de forma clara el nom i cognoms de la persona autora i el títol de la tesi doctoral. No s'autoritza la seva reproducció o altres formes d'explotació efectuades amb finalitats de lucre ni la seva comunicació pública des d'un lloc aliè al servei TDX. Tampoc s'autoritza la presentació del seu contingut en una finestra o marc aliè a TDX (framing). Aquesta reserva de drets afecta tant als continguts de la tesi com als seus resums i índexs.

Este ítem aparece en la(s) siguiente(s) colección(ones)